Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacodynamics Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01276509
What this trial is testing

Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease

Who this might be right for
Crohn's Disease
Shire 265
Early research (Phase 1)Study completedNCT01814839
What this trial is testing

A Phase 1, Single- and Multi-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN-TTRSC (Revusiran) in Healthy Volunteers

Who this might be right for
TTR-mediated Amyloidosis
Alnylam Pharmaceuticals 85
Early research (Phase 1)Active Not RecruitingNCT06783881
What this trial is testing

Single-ascending Dose Study of Kylo-12 in Healthy Subjects

Who this might be right for
Hypertriglyceridemia
Kylonova (Xiamen) Biopharma co., LTD. 50
Early research (Phase 1)Study completedNCT01861509
What this trial is testing

BP-C1 in Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast CancerStage IV Breast Cancer
Meabco A/S 10
Large-scale testing (Phase 3)WithdrawnNCT01925092
What this trial is testing

Mifepristone in Children With Refractory Cushing's Disease

Who this might be right for
Cushing's Disease
Corcept Therapeutics
Early research (Phase 1)Ended earlyNCT03387332
What this trial is testing

APG-1252 in Patients With SCLC or Advanced Solid Tumors

Who this might be right for
Small Cell Lung Cancer and Other Solid Tumors
Ascentage Pharma Group Inc. 24
Testing effectiveness (Phase 2)Study completedNCT04311632
What this trial is testing

A Dose Escalation Study in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
ITB-Med LLC 13
Early research (Phase 1)Ended earlyNCT05861947
What this trial is testing

Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies

Who this might be right for
RelapseAdvanced Malignant NeoplasmNon Small Cell Lung Cancer+5 more
Aurigene Discovery Technologies Limited 21
Early research (Phase 1)Study completedNCT01947738
What this trial is testing

Safety Study of VBY-891 in Healthy Volunteers After Single or Multiple (7 Days) of Oral Dosing (VBY891P1)

Who this might be right for
Healthy
Virobay Inc. 89
Early research (Phase 1)Study completedNCT01608243
What this trial is testing

Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts

Who this might be right for
AsthmaHouse Dust Mite Allergy
Stallergenes Greer 94
Testing effectiveness (Phase 2)Study completedNCT03334058
What this trial is testing

Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus

Who this might be right for
Pemphigus VulgarisPemphigus Foliaceus
argenx 34
Early research (Phase 1)Study completedNCT05490017
What this trial is testing

To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Doses of KP104

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Kira Pharmacenticals (US), LLC. 80
Early research (Phase 1)Looking for participantsNCT06366789
What this trial is testing

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
AML With Gene Mutations
Lomond Therapeutics Holdings, Inc. 150
Post-approval studies (Phase 4)Study completedNCT01192568
What this trial is testing

Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder

Who this might be right for
Overactive DetrusorNeurogenic Bladder
AbbVie 52
Early research (Phase 1)Study completedNCT01129258
What this trial is testing

Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders
Pfizer 110
Early research (Phase 1)Study completedNCT02629289
What this trial is testing

A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants

Who this might be right for
Neutropenia
Pfizer 153
Testing effectiveness (Phase 2)Study completedNCT05638737
What this trial is testing

A Study in Participants With Non-cirrhotic NASH With Fibrosis

Who this might be right for
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
AstraZeneca 112
Testing effectiveness (Phase 2)Study completedNCT04686175
What this trial is testing

Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency

Who this might be right for
Ectonucleotide Pyrophosphatase/phosphodiesterase1 DeficiencyAutosomal Recessive Hypophosphatemic RicketsGeneralized Arterial Calcification of Infancy
Inozyme Pharma 9
Large-scale testing (Phase 3)Looking for participantsNCT05076175
What this trial is testing

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Bristol-Myers Squibb 120
Testing effectiveness (Phase 2)Study completedNCT00358449
What this trial is testing

Intravenous Mepolizumab In Children With Eosinophilic Esophagitis

Who this might be right for
Oesophagitis, Eosinophilic
GlaxoSmithKline 84
Next Page